Levy Issac, Shah Rachana Prashant, Mukhija Ritika, Nanavaty Mayank A
Sussex Eye Hospital, University Hospitals Sussex NHS Foundation Trust, Brighton, United Kingdom.
Department of Ophthalmology, Rabin Medical Center, Petach Tikva, Israel.
Front Med (Lausanne). 2025 Feb 21;12:1522383. doi: 10.3389/fmed.2025.1522383. eCollection 2025.
Mini-monovision is a vision correction technique that allows for a broader spectrum of spectacle independence while minimizing anisometropia. This systemic review aims to evaluate the clinical outcomes of pseudophakic mini-monovision with three types of intraocular lenses (IOLs): monofocal, enhanced monofocal, and extended depth of focus (EDOF).
A comprehensive literature search was conducted using PubMed and MEDLINE to identify studies reporting mini-monovision outcomes within the three categories of IOLs up to July 2024. Inclusion criteria were studies with more than 20 patients, target refraction to achieve mini-monovision difference in the fellow eye, and minimum follow-up of 3 months. The primary outcome measure was uncorrected binocular intermediate visual acuity (UCIVA). The secondary outcomes were binocular uncorrected distance visual acuity (UCDVA), binocular uncorrected near visual acuity (UCNVA), patient-reported outcomes measures (PROMs), spectacle independence, contrast sensitivity, photic phenomenon, enhancement surgeries and IOL exchange.
A total of 113 studies were screened, of which 19, with a total of 1,530 patients, were eligible for inclusion in this review. Mean logMAR binocular UCIVA was 0.16 ± 0.01, 0.11 ± 0.06, 0.08 ± 0.07 ( = 0.41), and mean logMAR UCDVA was 0.08 ± 0.05, 0.04 ± 07, 0.04 ± 0.04 ( = 0.36), in the monofocal, enhanced monofocal, and EDOF groups, respectively. The mean spectacle independence rate was 51% ± 22.1, 55% ± 35.4 and 63.4% ± 24.6 ( = 0.05), respectively, in the monofocal, enhanced monofocal and EDOF groups. A comparable low incidence of halos and glare was observed when enhanced monofocal lenses were evaluated against traditional monofocal lenses. EDOF lenses have, however, demonstrated mixed results. The complications, IOL exchange, and excimer laser enhancement rates were low across all groups.
While enhanced monofocal and EDOF IOLs may provide slightly better binocular intermediate visual outcomes and higher spectacle independence compared to monofocal lenses with regards to mini-monovision and intermediate vision performance, the differences are not statistically significant. All three IOL types exhibit high patient satisfaction rates when choosing a mini-monovision approach with decreased dependence on spectacles.
微单眼视力矫正技术是一种视力矫正方法,它能在使屈光参差最小化的同时,让患者在更大程度上摆脱眼镜。本系统评价旨在评估三种类型人工晶状体(IOL)用于假晶状体眼微单眼视力矫正的临床效果,这三种人工晶状体分别为:单焦点、增强型单焦点和扩展景深(EDOF)型。
通过PubMed和MEDLINE进行全面的文献检索,以确定截至2024年7月报告上述三类人工晶状体微单眼视力矫正效果的研究。纳入标准为:研究对象超过20例、对侧眼用于实现微单眼视力差异的目标屈光度数、以及至少3个月的随访时间。主要结局指标为双眼未矫正的中间视力(UCIVA)。次要结局指标包括双眼未矫正的远视力(UCDVA)、双眼未矫正的近视力(UCNVA)、患者报告结局指标(PROMs)、摆脱眼镜的程度、对比敏感度、光现象、增效手术和人工晶状体置换。
共筛选出113项研究,其中19项符合纳入本评价的标准,涉及患者共1530例。单焦点、增强型单焦点和EDOF组的平均logMAR双眼UCIVA分别为0.16±0.01、0.11±0.06、0.08±0.07(P = 0.41),平均logMAR UCDVA分别为0.08±0.05、0.04±0.07、0.04±0.04(P = 0.36)。单焦点、增强型单焦点和EDOF组的平均摆脱眼镜率分别为51%±22.1、55%±35.4和63.4%±24.6(P = 0.05)。在将增强型单焦点人工晶状体与传统单焦点人工晶状体进行比较时,观察到光晕和眩光的发生率较低。然而,EDOF人工晶状体的结果不一。所有组的并发症、人工晶状体置换和准分子激光增效率均较低。
在微单眼视力矫正和中间视力表现方面,与单焦点人工晶状体相比,增强型单焦点和EDOF人工晶状体可能在双眼中间视力结果和摆脱眼镜程度上略优,但差异无统计学意义。当选择微单眼视力矫正方法且减少对眼镜的依赖时,这三种类型的人工晶状体均显示出较高的患者满意度。